Text Size
Trial record 1 of 4 for:    bcg diabetes
Previous Study | Return to List | Next Study

Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Massachusetts General Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Iacocca Foundation
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00607230
First received: January 22, 2008
Last updated: January 5, 2011
Last verified: January 2011
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2011
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by Massachusetts General Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):